Nasal polyps with more intense epithelial eosinophil infiltration respond worse to long-term low-dose treatment by clarithromycin

Advances in Clinical and Experimental Medicine

Volumn 20, Issue 3, 2011, Pages 325-334

  Perić, Aleksandar ^a   Vojvodić, Danilo ^a   Vukomanović Durdević, Biserka ^a  

^a UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Allergy; Clarithromycin; Eosinophils; Epithelium; Nasal polyposis

Indexed keywords

CLARITHROMYCIN; MOMETASONE FUROATE;

ADULT; AGED; ALLERGIC RHINITIS; ALLERGY TEST; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPIC POLYPECTOMY; ENDOSCOPIC SINUS SURGERY; ENDOSCOPY; EOSINOPHIL; EOSINOPHIL COUNT; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; LAMINA PROPRIA; LONG TERM CARE; LOW DRUG DOSE; MALE; NOSE POLYP; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT OUTCOME;

EID: 84860389133     PISSN: 1230025X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Perić A, Vojvodić D, Baletić N, Perić AV, Miljanović O: Immunomodulatory and clinical effects of long-term low-dose macrolide treatment of chronic rhinosinusitis with nasal polyposis. J Med Biochem 2011, 30, 45-50.
2. Fan GK, Wang H, Takenaka H: Eosinophil infiltration and activation in nasal polyposis. Acta Otolaryngol 2007, 127, 521-526. (Pubitemid 46633786)
3. Fokkens WJ, Lund VJ, Mullol J: European Position Paper on Rhinosinusitis and Nasal Polyps Group. EP30S 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologist. Rhinology 2007, 45, 97-101.
4. Lildholdt T, Rundcrantz H, Bende M, Larsen K: Glucocorticoid treatment for nasal polyps: the use of topical budesonide powder, intramuscular betamethasone, and surgical treatment. Arch Otolaryngol Head Neck Surg 1997, 123, 595-600. (Pubitemid 27258448)
5. Collins TJ: ImageJ for microscopy. Bio Techniques 2007, 43, Suppl, 25-30.
6. Badia L, Lund VJ: Topical corticosteroids in nasal polyposis. Drugs 2001, 61, 573-578. (Pubitemid 32453369)
7. Kanai N, Denburg J, Jordana M, Dolovich J: Nasal polyp inflammation. Effect of topical nasal steroids. Am J Respir Crit Care Med 1994, 150, 1094-1100. (Pubitemid 24318041)
8. Cervin A, Wallwork B: Macrolide therapy of chronic rhinosinusitis. Rhinology 2007, 45, 259-267.
9. Ichimura K, Shimazaki Y, Ishibashi T, Higo R: Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996, 23, 48-56. (Pubitemid 26185193)
10. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H: Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000, 14, 143-148. (Pubitemid 30441214)
11. Haruna S, Shimada C, Ozawa M, Fukami S, Moriyama H: A study of poor responders for long-term, low-dose macrolide administration for chronic rhinosinusitis. Rhinology 2009, 40, 66-71.
12. Nonaka M, Pawankar R, Tomiyama S, Yagi T: A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 1999, 13, 267-272.
13. Rostkowska-Nadolska B, Pazdro-Zastawny K, Ziółkowski P, Gamian E, Jaworska M, Bochnia M et al.: Expression of basic fibroblast growth factor in nasal polyps. Adv Clin Exp Med 2008, 17, 33-40. (Pubitemid 351611693)
14. Fra̧czek M, Rostkowska-Nadolska B, Sliupkas-Dyrda E, Kuśmierz D, Pniak J, Latocha M: The influence of vitamin D derivates on the expression of apoptotic genes in nasal polyp fibroblasts. Adv Clin Exp Med 2010, 19, 679-684.
15. Perić A, Vojvodić D, Baletić N, Perić A, Miljanović O: Influence of allergy on the immunomodulatory and clinical effects of long-term low-dose macrolide treatment of nasal polyposis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010, 154, 327-334.
16. Nonaka M, Pawankar R, Saji F, Yagi T: Effect of roxithromycin on IL-8 synthesis and proliferation of nasal polyp fibroblasts. Acta Otolaryngol Suppl 1998, 539, 71-75. (Pubitemid 29111468)
17. Ohori J, Ushikai M, Sun D, Nishimoto K, Sagara Y, Fukuiwa T et al.: TNF-α upregulates VCAM-1 and NF-κB in fibroblasts from nasal polyps. Auris Nasus Larynx 2007, 34, 177-183. (Pubitemid 46603200)
18. Saji F, Nonaka M, Pawankar R: Expression of RANTES by IL-1β and TNF-α stimulated nasal polyp fibroblasts. Auris Nasus Larynx 2000, 27, 247-252. (Pubitemid 30251878)
19. Xu G, Xia JH, Zhou H, Yu CZ, Zhang Y, Zuo KJ, et al.: Interleukin-6 is essential for Staphylococcal exotoxin B-induced T regulatory cell insufficiency in nasal polyps. Clin Exp Allergy 2009, 39, 829-837.
20. Pawliczak R, Kowalski ML, Danilewicz M, Wagrowska-Danilewicz M, Lewandowski A: Distribution of mast cells and eosinophils in nasal polyps from atopic and nonatopic subjects: a morphometric study. Am J Rhinol 1997, 11, 257-262. (Pubitemid 127773052)
21. Cheng W, Zheng C, Tian J, Shi G: T helper cell population and eosinophilia in nasal polyps. J Investig Allergol Clin Immunol 2007, 17, 297-301. (Pubitemid 350012543)
22. Saitoh T, Kusunoki T, Yao T, Kawano K, Kojima Y, Miyahara K, et al.: Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis. Rhinology 2009, 47, 275-279.